| 摘要 |
This invention is directed to a method for treating or preventing multiple sclerosis (MS), treating multiple sclerosis symptoms or preventing the continual chronic deterioration caused by multiple sclerosis (MS), comprising administering a conjugate of hydroxyproline and docosahexaenoic acid (DHA) according to formula MW-001. |
